Surrozen, Inc.
SRZN • NASDAQ
Surrozen, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Craig C. Parker, with a market cap of $332.0M.
CEOCraig C. Parker
Next Earnings
Upcoming earnings announcement for Surrozen, Inc.
Date
Friday, May 8, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.99
Revenue Estimate
$5.2M
Earnings History
Past 12 earnings reports for Surrozen, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Q4 2025 | -$20.13Est: -$1.30 | -1448.5% | $500.0KEst: $661.0K | -24.4% |  10-K |
| Nov 7, 2025 | Q3 2025 | -$8.36Est: -$1.17 | -614.5% | $983.0K | — | 10-Q |
| Aug 8, 2025 | Q2 2025 | $2.55Est: -$1.23 | +307.3% | $983.0K | — | 10-Q |
| May 9, 2025 | Q1 2025 | -$7.43Est: -$2.71 | -174.2% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$9.10Est: -$2.64 | -244.7% | - | — | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.44Est: -$2.46 | +82.1% | $10.0M | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$7.99Est: -$2.79 | -186.4% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$4.24Est: -$4.25 | +0.2% | - | — | 10-Q |
| Apr 10, 2024 | Q4 2023 | -$4.38Est: -$2.95 | -48.5% | - | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$5.10Est: -$4.35 | -17.2% | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$4.65Est: -$6.15 | +24.4% | - | — | 10-Q |
| May 10, 2023 | Q1 2023 | -$7.20Est: -$5.55 | -29.7% | - | — | — |